The first reported 20-year prospective follow-up of middle-aged children of Alzheimer patients failed to find statistically significant neurocognitive decline. Because that report did not include a comparison group, the current study compared the 20-year follow-up scores with scores obtained on the same 8 measures by an age-comparable sample of healthy adults without a family history of Alzheimer’s disease. Both were convenience samples (n = 24). Statistical analyses (correcting for age) yielded no significant group differences in neurocognitive scores but did show a significantly higher mean score for the comparison group on the Mini-Mental State Examination (29.5 vs 28.8, P = .003, controlling for age). Even though this finding suggests that adult children of a parent with Alzheimer’s disease performed well on a limited neurocognitive battery and on the Mini-Mental State Examination, the findings are preliminary and require confirmation on large representative samples with appropriate controls and long-term follow-up.
Jarvik LF, La Rue A, Gokhman I, et al.Middle-aged children of Alzheimer parents, a pilot study: stable neurocognitive performance at 20-year follow-up. J Geriatr Psychiatry Neurol2005; 18:187-191.
3.
Small BJ, Herlitz A, Fratiglioni L, et al.Cognitive predictors of incident Alzheimer’s disease: a prospective longitudinal study. Neuropsychology1997; 11:413-420.
4.
Small GW, Ercoli LM, Silverman DH, et al.Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease. Proc Natl Acad Sci U S A2000; 97:6037-6042.
5.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12:189-198.
6.
Small GW, Mazziotta JC, Collins MT, et al.Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA1995; 273:942-947.
7.
Wechsler D. Manual for the Wechsler Adult Intelligence Scale. New York: The Psychological Corporation, 1955.
8.
Benton AL. Revised visual retention test. New York: The Psychological Corporation, 1974.
9.
Hamilton M.The assessment of anxiety states by rating. Br J Med Psychol1959; 32:50-55.
10.
Hamilton M.A rating scale for depression. J Neurol Neurosurg Psychiatry1960; 23:56-62.
11.
Small BJ, Mobly JL, Laukka EJ, et al.Cognitive deficits in preclinical Alzheimer’s disease. Acta Neurol Scand Suppl2003; 179:29-33.
12.
Kawas CH, Corrada MM, Brookmeyer R, et al.Visual memory predicts Alzheimer’s disease more than a decade before diagnosis. Neurology2003; 60:1089-1093.
13.
Zonderman AB, Giambra LM, Arenberg D, et al.Changes in immediate visual memory predict cognitive impairment. Arch Clin Neuropsychol1995; 10:111-123.
14.
Giambra LM, Arenberg D, Kawas C, et al.Adult life span changes in immediate visual memory and verbal intelligence. Psychol Aging1995; 10:123-139.
15.
Chen P, Ratcliff G, Belle SH, et al.Patterns of cognitive decline in pre-symptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry2001; 58:853-858.
16.
Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA1993; 269:2386-2391.
17.
Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J.Age-specific norms for the Mini-Mental State Exam. Neurology1988; 38:1565-1568.
18.
Ercoli LM, Siddarth P, Dunkin JJ, et al.MMSE items predict cognitive decline in persons with genetic risk for Alzheimer’s disease. J Geriatr Psychiatry Neurol2003; 16:67-73.
19.
Rice F, Abraham R, Rudrasingham V, et al.Memory for new information as a cognitive marker of liability to Alzheimer’s disease in a high risk group: a research note. Int J Geriatr Psychiatry2003; 18:155-160.
20.
Bäckman L, Jones S, Berger AL, et al.Cognitive impairment in preclinical Alzheimer’s disease: a meta-analysis. Neuropsychology2005; 19:520-531.
21.
Hom J, Turner MB, Risser R, et al.Cognitive deficits in asymptomatic first-degree relatives of Alzheimer’s disease patients. J Clin Exp Neuropsychol1994; 16:568-576.
22.
Russell EW. A multiple scoring method for the assessment of complex memory functions. J Consult Clin Psychol1975; 43:800-809.
23.
Reitan RM, Wolfson D.The Halstead-Reitan Neuropsychological Test Battery. Theory and clinical interpretation. Tucson: Neuropsychology Press, 1985.
24.
Rentz DM, Huh TJ, Faust RR, et al.Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology2004; 18:38-49.
25.
Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA. Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. J Geriatr Psychiatry Neurol2005; 18:218-223.
26.
Lavretsky H, Kumar A.Clinically significant non-major depression: old concepts, new insights. Am J Geriatr Psychiatry2002; 10:239-255.
27.
Alexopoulos G, Young RC, Meyers BS. Geriatric depression: age of onset and dementia. Biol Psychiatry1993; 34:141-145.
28.
Ringman JM, Diaz-Olavarrieta C, Rodriguez Y, et al.Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin. J Neurol Neurosurg Psychiatry2004; 75:500-502.
29.
Green RC, Cupples LA, Kurz A, et al.Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol2003; 60:753-759.
30.
Rasgon N, Jarvik LF. Insulin resistance, affective disorders and Alzheimer’s disease: review and hypothesis. J Gerontol A Biol Sci Med Sci2004; 59:178-183.
